Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHILUCA: The Development of Muscle Mass, Muscle Strength, and Muscle Function in Patients With Lung Cancer During Cancer Treatment

NCT06730685 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT06730685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06730685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHILUCA: The Development of Muscle Mass, Muscle Strength, and Muscle Function in Patients With Lung Cancer During Cancer Treatment
Lead sponsor
Zealand University Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 12, 2024
Completion date
April 1, 2028
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer (nsclc), small cell lung cancer (sclc)